π¨ RAPT: GSK's Tender Offer for RAPT Therapeutics Successfully Completed; Merger Imminent at $58.00/Share
New Filing: SC TO-T/A
Ticker: RAPT | Score: 10/10 | Sentiment: Positive
Summary (Wiseek AI)
GSK's tender offer for RAPT Therapeutics has successfully concluded, with 93.36% of shares tendered, paving the way for the acquisition to finalize at $58.00 per share and subsequent delisting.
Further Research: π€ Wiseek AI Analysis | ποΈ Original SEC Filing
Automated via Wiseek.ai β Identifying market-moving SEC insights.
Posted Mar 3, 2026, 11:38 AM UTC
10